Muscarinic acetylcholine receptor antagonists

Details for Australian Patent Application No. 2004281724 (hide)

Owner Glaxo Group Limited

Inventors Wan, Zehong; Busch-Petersen, Jakob; Yan, Hongxing; Zhu, Chongjie; Palovich, Michael R.

Agent Davies Collison Cave

Pub. Number AU-B-2004281724

PCT Pub. Number WO2005/037280

Priority 60/511,009 14.10.03 US

Filing date 12 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 15 July 2010

International Classifications

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/037280 Priority application(s): WO2005/037280

2 August 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Muscarinic acetylcholine receptor antagonists

15 July 2010 Application Accepted

  Published as AU-B-2004281724

11 November 2010 Standard Patent Sealed

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281729-Methods and reagents for the treatment of immunoinflammatory disorders

2004281721-Cassette for handling and holding tissue samples during processing, embedding and microtome procedures, and methods therefor